Dr. Neal Patel

Dr. Neal Patel
Dr. Neal Patel , a Georgia native, earned his medical degree from Chicago Medical School as part of an engineering in medicine program with the Illinois Institute of Technology where he graduated Cum Laude with a degree in Molecular Biochemistry and Biophysics. After completing residency in Urologic Surgery at Rutgers Robert Wood Johnson Medical School in New Jersey, he joined the USC Institute of Urology as a Felix and Mildred Yip Fellow in Advanced Robotics and Laparoscopy. Dr. Patel has been active with the American Medical Association, the Illinois State Medical Society and the Chicago Medical Society. He has served on the Board of Trustees of the Chicago Medical Society, and has held multiple leadership positions within organized medicine at both local and national levels. In 2009, Dr. Patel was invited to attend the TEDMED inaugural conference in San Diego and has since been an invited alumnus. During his time at USC, Dr. Patel performed hundreds of benign and oncologic Robotic procedures using the Intuitive Surgical’s DaVinci™ Xi and Si platforms and also consulted with Intuitive Surgical in testing future technologies. While Dr. Patel enjoys all aspects of urologic surgery he specializes in new advanced robotic techniques such as Cystectomy with Intra-corporeal Diversions, Retroperitoneal Access Robotic Surgery, and Zero Ischemia partial nephrectomy. Dr. Patel has co-authored a number publications, patents, and textbook chapters, as well as presented research at many national conferences. He has been nationally recognized on his work with neuro-protective nanosphere drug delivery technologies as well as cytoreduction for metastatic prostate cancer. He has also founded two medical device companies and has a keen interest in medical and biotechnology that improves patient experience and outcomes while decreasing the cost of healthcare in the U.S. and around the world. Dr. Patel is a strong patient advocate and his satisfaction lies in providing them the opportunity to return normalcy to their lives.
Medical School:

Chicago Medical School


Rutgers Robert Wood Johnson Medical School


Advanced Robotics Fellowship: University of Southern California Keck School of Medicine

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only